دورية أكاديمية

Screening for celiac disease among patients of the gastroenterological profile

التفاصيل البيبلوغرافية
العنوان: Screening for celiac disease among patients of the gastroenterological profile
المؤلفون: S. V. Bykova, Elena A. Sabelnikova, R. B. Gudkova, K. K. Noskova, L. M. Krums, A. I. Parfenov
المصدر: Терапевтический архив, Vol 93, Iss 2, Pp 145-149 (2021)
بيانات النشر: "Consilium Medicum" Publishing house, 2021.
سنة النشر: 2021
المجموعة: LCC:Medicine
مصطلحات موضوعية: celiac disease, the detection rate of antibodies to tissue transglutaminase, Medicine
الوصف: Aim. To determine the frequency of celiac disease (CD) among gastroenterological patients and criteria for its active detection. Materials and methods. 1.358 patients referred for gastroenterologist consultation from 2016 to 2019 was conducted, of which 140 had CD (339 males 24.9%; 1019 females 75.1%). The average age was 40.415.4 (1886 years). All patients were determined anti-TTG IgA, IgG, and analyzed the clinical symptoms and analysis. The results were subjected to statistical processing Statistica 13.3 (StatSoft Inc., USA). Results. In patients without CD (1218 people), high level of anti-TTG IgA and IgG was observed in 59 (4.8%), an increase in anti-TTG IgA in 54 (4.4%), and anti-TTG IgG in 38 patients (3.1%). The CD diagnosis confirmed in 51 patients (4.2%). The main symptoms were diarrhea (88%), abdominal pain (60.7%), bloating (73.8%), nausea (40.3%), weight loss (44.3%). Anemia was determined in 31.6%, serum iron 33%, hypoproteinemia 12.6%, hypoalbuminemia 12%, hypokalemia 5.48%, hypocalcemia 21.9%. An increase in the level of AST 14.5%, ALT 14.6%. Comparative analysis showed that in the group with newly detected CD, anemia, malabsorption syndrome, increase AST, ALT were significantly more frequent than in patients with normal antibodies, which confirms the need to detect CD among patients with these laboratory abnormalities. Conclusion. The incidence of CD among patients with a gastroenterological symptoms was 4.2%. Analysis of clinical and laboratory data has shown that a comprehensive analysis of clinical symptoms and laboratory indicators at the stage of primary treatment will allow timely identification of CD patients and prescribe GFD.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: Russian
تدمد: 0040-3660
2309-5342
00403660
Relation: https://ter-arkhiv.ru/0040-3660/article/viewFile/64697/47575; https://doaj.org/toc/0040-3660; https://doaj.org/toc/2309-5342
DOI: 10.26442/00403660.2021.02.200625
URL الوصول: https://doaj.org/article/ee72c6547b3647298dedd962a7e35c3f
رقم الأكسشن: edsdoj.72c6547b3647298dedd962a7e35c3f
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:00403660
23095342
DOI:10.26442/00403660.2021.02.200625